Ramiah Investment Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Ramiah Investment Group's BIIB Position: Q2 2026 in Review
Ramiah Investment Group opened a new position in Biogen (BIIB) in Q2 2026: 2,085 shares worth $450K. The stake represents 0.34% of the portfolio and ranks #43 among its holdings. This is a return to the name: Ramiah Investment Group previously reported a position in BIIB as recently as Q1 2025.
Ramiah Investment Group first reported a position in BIIB in Q2 2024 and has held it in 5 quarters since. The position peaked at $820K in Q2 2024. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Ramiah Investment Group held 2,085 shares of Biogen worth $450K as of Q2 2026.
- Biogen was a new Ramiah Investment Group position in Q2 2026.
- Biogen made up 0.34% of Ramiah Investment Group's portfolio in Q2 2026, its #43 holding.
- Ramiah Investment Group first reported a position in Biogen in Q2 2024 and has held it in 5 quarters since.
- Ramiah Investment Group's Biogen position peaked at $820K in Q2 2024.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.